These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38160360)

  • 1. A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5.
    Mahzarnia A; Lutz MW; Badea A
    J Alzheimers Dis; 2024; 97(2):635-648. PubMed ID: 38160360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Continuous Extension of Gene Set Enrichment Analysis using the Likelihood Ratio Test Statistics Identifies VEGF as a Candidate Pathway for Alzheimer's disease.
    Mahzarnia A; Lutz MW; Badea A
    bioRxiv; 2023 Aug; ():. PubMed ID: 37662249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease.
    Yang HS; Yau WW; Carlyle BC; Trombetta BA; Zhang C; Shirzadi Z; Schultz AP; Pruzin JJ; Fitzpatrick CD; Kirn DR; Rabin JS; Buckley RF; Hohman TJ; Rentz DM; Tanzi RE; Johnson KA; Sperling RA; Arnold SE; Chhatwal JP
    Brain; 2024 Jun; 147(6):2158-2168. PubMed ID: 38315899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
    Hohman TJ; Bell SP; Jefferson AL;
    JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.
    Xu Y; Vasiljevic E; Deming YK; Jonaitis EM; Koscik RL; Van Hulle CA; Lu Q; Carboni M; Kollmorgen G; Wild N; Carlsson CM; Johnson SC; Zetterberg H; Blennow K; Engelman CD
    J Alzheimers Dis; 2023; 94(4):1587-1605. PubMed ID: 37482996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.
    Han MR; Schellenberg GD; Wang LS;
    BMC Neurol; 2010 Oct; 10():90. PubMed ID: 20932310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between APOE genotype, CSF Tau and cognition across the Alzheimer's disease spectrum, moderation and mediation role of insula network connectivity.
    Zhu Y; Wu Y; Lv X; Wu J; Shen C; Tang Q; Wang G;
    CNS Neurosci Ther; 2024 Jan; 30(1):e14401. PubMed ID: 37577852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Amyloid-β, Total Tau, and Neurofilament Light Chain Across the Alzheimer's Disease Clinical Spectrum: A Population-Based Study.
    Dong Y; Hou T; Li Y; Liu R; Cong L; Liu K; Liu C; Han X; Ren Y; Tang S; Winblad B; Blennow K; Wang Y; Du Y; Qiu C
    J Alzheimers Dis; 2023; 96(2):845-858. PubMed ID: 37899059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer's disease.
    Mahoney ER; Dumitrescu L; Moore AM; Cambronero FE; De Jager PL; Koran MEI; Petyuk VA; Robinson RAS; Goyal S; Schneider JA; Bennett DA; Jefferson AL; Hohman TJ
    Mol Psychiatry; 2021 Mar; 26(3):888-896. PubMed ID: 31332262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome.
    Gorijala P; Aslam MM; Dang LT; Xicota L; Fernandez MV; Sung YJ; Fan KH; Feingold E; Surace EI; Chhatwal JP; Hom CL; ; ; Hartley SL; Hassenstab J; Perrin RJ; Mapstone M; Zaman SH; Ances BM; Kamboh MI; Lee JH; Cruchaga C
    Alzheimers Dement; 2024 Feb; 20(2):1038-1049. PubMed ID: 37855447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole blood transcript and protein abundance of the vascular endothelial growth factor family relate to cognitive performance.
    Libby JB; Seto M; Khan OA; Liu D; Petyuk V; Oliver NC; Choi MJ; Whitaker M; Patterson KL; Arul AB; Gifford KA; Blennow K; Zetterberg H; Dumitrescu L; Robinson RA; Jefferson AL; Hohman TJ
    Neurobiol Aging; 2023 Apr; 124():11-17. PubMed ID: 36680854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-tau and neurodegeneration mediate the effect of β-amyloid on cognition in non-demented elders.
    Ma LZ; Hu H; Wang ZT; Ou YN; Dong Q; Tan L; Yu JT
    Alzheimers Res Ther; 2021 Dec; 13(1):200. PubMed ID: 34911582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of abnormal Alzheimer's disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples.
    Wolfsgruber S; Molinuevo JL; Wagner M; Teunissen CE; Rami L; Coll-Padrós N; Bouwman FH; Slot RER; Wesselman LMP; Peters O; Luther K; Buerger K; Priller J; Laske C; Teipel S; Spottke A; Heneka MT; Düzel E; Drzezga A; Wiltfang J; Sikkes SAM; van der Flier WM; Jessen F;
    Alzheimers Res Ther; 2019 Jan; 11(1):8. PubMed ID: 30654834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults.
    Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL
    Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AD and non-AD mediators of the pathway between the APOE genotype and cognition.
    Nichols E; Brickman AM; Casaletto KB; Dams-O'Connor K; George KM; Kumar RG; Palta P; Rabin JS; Satizabal CL; Schneider J; Pa J; La Joie R
    Alzheimers Dement; 2023 Jun; 19(6):2508-2519. PubMed ID: 36516004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer's Disease Risks.
    Kim H; Levine A; Cohen D; Gehrman P; Zhu X; Devanand DP; Lee S; Goldberg TE;
    J Alzheimers Dis; 2022; 87(4):1567-1580. PubMed ID: 35491776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Chen TB; Lai YH; Ke TL; Chen JP; Lee YJ; Lin SY; Lin PC; Wang PN; Cheng IH
    Dement Geriatr Cogn Disord; 2019; 48(3-4):180-195. PubMed ID: 31991443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease.
    Drake JD; Chambers AB; Ott BR; Daiello LA;
    J Alzheimers Dis; 2021; 80(4):1553-1565. PubMed ID: 33720880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.